CN111480838A - Nutrition composite powder for puerpera in lactation period and preparation method thereof - Google Patents
Nutrition composite powder for puerpera in lactation period and preparation method thereof Download PDFInfo
- Publication number
- CN111480838A CN111480838A CN202010452809.3A CN202010452809A CN111480838A CN 111480838 A CN111480838 A CN 111480838A CN 202010452809 A CN202010452809 A CN 202010452809A CN 111480838 A CN111480838 A CN 111480838A
- Authority
- CN
- China
- Prior art keywords
- powder
- parts
- vitamin
- nutritional
- women
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 159
- 230000006651 lactation Effects 0.000 title claims abstract description 59
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 51
- 239000002131 composite material Substances 0.000 title claims abstract description 31
- 230000035764 nutrition Effects 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title abstract description 13
- 229940088594 vitamin Drugs 0.000 claims abstract description 42
- 229930003231 vitamin Natural products 0.000 claims abstract description 42
- 235000013343 vitamin Nutrition 0.000 claims abstract description 42
- 239000011782 vitamin Substances 0.000 claims abstract description 42
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims abstract description 36
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 32
- 102000008186 Collagen Human genes 0.000 claims abstract description 31
- 108010035532 Collagen Proteins 0.000 claims abstract description 31
- 229920001436 collagen Polymers 0.000 claims abstract description 31
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 31
- 241000251468 Actinopterygii Species 0.000 claims abstract description 26
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 26
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 26
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 25
- 239000011707 mineral Substances 0.000 claims abstract description 25
- 235000017060 Arachis glabrata Nutrition 0.000 claims abstract description 19
- 235000010777 Arachis hypogaea Nutrition 0.000 claims abstract description 19
- 235000018262 Arachis monticola Nutrition 0.000 claims abstract description 19
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims abstract description 19
- 235000020232 peanut Nutrition 0.000 claims abstract description 19
- 229940090949 docosahexaenoic acid Drugs 0.000 claims abstract description 18
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 17
- 235000013406 prebiotics Nutrition 0.000 claims abstract description 17
- 239000000126 substance Substances 0.000 claims abstract description 17
- 235000019197 fats Nutrition 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 210000000845 cartilage Anatomy 0.000 claims abstract description 13
- 235000013305 food Nutrition 0.000 claims abstract description 10
- 235000021404 traditional food Nutrition 0.000 claims abstract description 5
- 235000014633 carbohydrates Nutrition 0.000 claims description 31
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 29
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 29
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 24
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 24
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 24
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 24
- 235000018102 proteins Nutrition 0.000 claims description 23
- 239000005913 Maltodextrin Substances 0.000 claims description 19
- 229920002774 Maltodextrin Polymers 0.000 claims description 19
- 229940035034 maltodextrin Drugs 0.000 claims description 19
- 244000105624 Arachis hypogaea Species 0.000 claims description 18
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 16
- 108010038807 Oligopeptides Proteins 0.000 claims description 16
- 102000015636 Oligopeptides Human genes 0.000 claims description 16
- 229930003270 Vitamin B Natural products 0.000 claims description 16
- 235000019156 vitamin B Nutrition 0.000 claims description 16
- 239000011720 vitamin B Substances 0.000 claims description 16
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 15
- 229960000304 folic acid Drugs 0.000 claims description 15
- 235000019152 folic acid Nutrition 0.000 claims description 15
- 239000011724 folic acid Substances 0.000 claims description 15
- 239000011575 calcium Substances 0.000 claims description 14
- 229910052791 calcium Inorganic materials 0.000 claims description 14
- 229960003512 nicotinic acid Drugs 0.000 claims description 14
- 229920001202 Inulin Polymers 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 13
- 210000002969 egg yolk Anatomy 0.000 claims description 13
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 13
- 229940029339 inulin Drugs 0.000 claims description 13
- 235000021388 linseed oil Nutrition 0.000 claims description 13
- 239000000944 linseed oil Substances 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 235000001968 nicotinic acid Nutrition 0.000 claims description 13
- 239000011664 nicotinic acid Substances 0.000 claims description 13
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 12
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 12
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 12
- 229940055726 pantothenic acid Drugs 0.000 claims description 12
- 239000011713 pantothenic acid Substances 0.000 claims description 12
- 235000019161 pantothenic acid Nutrition 0.000 claims description 12
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 11
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 11
- 229930003268 Vitamin C Natural products 0.000 claims description 11
- 229930003316 Vitamin D Natural products 0.000 claims description 11
- 229930003427 Vitamin E Natural products 0.000 claims description 11
- 240000008042 Zea mays Species 0.000 claims description 11
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 11
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 11
- 235000005822 corn Nutrition 0.000 claims description 11
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 11
- 230000000750 progressive effect Effects 0.000 claims description 11
- 235000019154 vitamin C Nutrition 0.000 claims description 11
- 239000011718 vitamin C Substances 0.000 claims description 11
- 235000019166 vitamin D Nutrition 0.000 claims description 11
- 239000011710 vitamin D Substances 0.000 claims description 11
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 11
- 229940046009 vitamin E Drugs 0.000 claims description 11
- 235000019165 vitamin E Nutrition 0.000 claims description 11
- 239000011709 vitamin E Substances 0.000 claims description 11
- 229940045997 vitamin a Drugs 0.000 claims description 11
- 229940046008 vitamin d Drugs 0.000 claims description 11
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 10
- 235000019155 vitamin A Nutrition 0.000 claims description 10
- 239000011719 vitamin A Substances 0.000 claims description 10
- 102000002322 Egg Proteins Human genes 0.000 claims description 8
- 108010000912 Egg Proteins Proteins 0.000 claims description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 8
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 8
- 229920002472 Starch Polymers 0.000 claims description 8
- 102000007544 Whey Proteins Human genes 0.000 claims description 8
- 108010046377 Whey Proteins Proteins 0.000 claims description 8
- 235000013345 egg yolk Nutrition 0.000 claims description 8
- 235000021119 whey protein Nutrition 0.000 claims description 8
- 238000007599 discharging Methods 0.000 claims description 7
- 238000000227 grinding Methods 0.000 claims description 7
- 238000007873 sieving Methods 0.000 claims description 7
- 235000019698 starch Nutrition 0.000 claims description 7
- 239000008107 starch Substances 0.000 claims description 7
- 240000002853 Nelumbo nucifera Species 0.000 claims description 6
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 6
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 5
- 229930003779 Vitamin B12 Natural products 0.000 claims description 5
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 5
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 5
- 229960002477 riboflavin Drugs 0.000 claims description 5
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 5
- 235000019163 vitamin B12 Nutrition 0.000 claims description 5
- 239000011715 vitamin B12 Substances 0.000 claims description 5
- 241000283690 Bos taurus Species 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 4
- 239000005715 Fructose Substances 0.000 claims description 4
- 229930091371 Fructose Natural products 0.000 claims description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 4
- 235000010469 Glycine max Nutrition 0.000 claims description 4
- 108010042653 IgA receptor Proteins 0.000 claims description 4
- 102000010445 Lactoferrin Human genes 0.000 claims description 4
- 108010063045 Lactoferrin Proteins 0.000 claims description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
- 102000014171 Milk Proteins Human genes 0.000 claims description 4
- 108010011756 Milk Proteins Proteins 0.000 claims description 4
- 229920001100 Polydextrose Polymers 0.000 claims description 4
- 102100034014 Prolyl 3-hydroxylase 3 Human genes 0.000 claims description 4
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 4
- 235000021307 Triticum Nutrition 0.000 claims description 4
- 229930003451 Vitamin B1 Natural products 0.000 claims description 4
- 229930003471 Vitamin B2 Natural products 0.000 claims description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 4
- 235000013339 cereals Nutrition 0.000 claims description 4
- 210000003022 colostrum Anatomy 0.000 claims description 4
- 235000021277 colostrum Nutrition 0.000 claims description 4
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 4
- 235000019425 dextrin Nutrition 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 235000013601 eggs Nutrition 0.000 claims description 4
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 4
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 4
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 4
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 4
- 229910052742 iron Inorganic materials 0.000 claims description 4
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims description 4
- 235000021242 lactoferrin Nutrition 0.000 claims description 4
- 229940078795 lactoferrin Drugs 0.000 claims description 4
- 239000008101 lactose Substances 0.000 claims description 4
- 235000021239 milk protein Nutrition 0.000 claims description 4
- 239000004006 olive oil Substances 0.000 claims description 4
- 235000008390 olive oil Nutrition 0.000 claims description 4
- 239000001259 polydextrose Substances 0.000 claims description 4
- 235000013856 polydextrose Nutrition 0.000 claims description 4
- 229940035035 polydextrose Drugs 0.000 claims description 4
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 4
- 235000020183 skimmed milk Nutrition 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 239000003549 soybean oil Substances 0.000 claims description 4
- 235000012424 soybean oil Nutrition 0.000 claims description 4
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 4
- 235000020357 syrup Nutrition 0.000 claims description 4
- 239000006188 syrup Substances 0.000 claims description 4
- 229960003495 thiamine Drugs 0.000 claims description 4
- 235000019871 vegetable fat Nutrition 0.000 claims description 4
- 235000013311 vegetables Nutrition 0.000 claims description 4
- 235000010374 vitamin B1 Nutrition 0.000 claims description 4
- 239000011691 vitamin B1 Substances 0.000 claims description 4
- 235000019164 vitamin B2 Nutrition 0.000 claims description 4
- 239000011716 vitamin B2 Substances 0.000 claims description 4
- 235000019158 vitamin B6 Nutrition 0.000 claims description 4
- 239000011726 vitamin B6 Substances 0.000 claims description 4
- 229940011671 vitamin b6 Drugs 0.000 claims description 4
- 235000008939 whole milk Nutrition 0.000 claims description 4
- 239000011701 zinc Substances 0.000 claims description 4
- 229910052725 zinc Inorganic materials 0.000 claims description 4
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 3
- 244000062793 Sorghum vulgare Species 0.000 claims description 3
- 240000008866 Ziziphus nummularia Species 0.000 claims description 3
- 235000015278 beef Nutrition 0.000 claims description 3
- 235000007215 black sesame Nutrition 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 235000019713 millet Nutrition 0.000 claims description 3
- 229920001542 oligosaccharide Polymers 0.000 claims description 3
- NEGYEDYHPHMHGK-UHFFFAOYSA-N para-methoxyamphetamine Chemical compound COC1=CC=C(CC(C)N)C=C1 NEGYEDYHPHMHGK-UHFFFAOYSA-N 0.000 claims description 3
- 229940071440 soy protein isolate Drugs 0.000 claims description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 3
- 235000019486 Sunflower oil Nutrition 0.000 claims description 2
- 235000013312 flour Nutrition 0.000 claims description 2
- 239000002600 sunflower oil Substances 0.000 claims description 2
- 244000098338 Triticum aestivum Species 0.000 claims 1
- 235000010755 mineral Nutrition 0.000 abstract description 22
- 210000003754 fetus Anatomy 0.000 abstract description 14
- 239000013589 supplement Substances 0.000 abstract description 10
- 206010010774 Constipation Diseases 0.000 abstract description 5
- 208000027418 Wounds and injury Diseases 0.000 abstract description 5
- 235000013336 milk Nutrition 0.000 abstract description 4
- 239000008267 milk Substances 0.000 abstract description 4
- 210000004080 milk Anatomy 0.000 abstract description 4
- 206010052428 Wound Diseases 0.000 abstract description 2
- 230000009977 dual effect Effects 0.000 abstract description 2
- 235000006694 eating habits Nutrition 0.000 abstract description 2
- 230000035876 healing Effects 0.000 abstract description 2
- 235000015097 nutrients Nutrition 0.000 abstract description 2
- 241001553178 Arachis glabrata Species 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 229960005069 calcium Drugs 0.000 description 13
- 108010073771 Soybean Proteins Proteins 0.000 description 10
- 235000019710 soybean protein Nutrition 0.000 description 9
- 239000003814 drug Substances 0.000 description 8
- 230000009286 beneficial effect Effects 0.000 description 6
- 230000035935 pregnancy Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 210000000582 semen Anatomy 0.000 description 5
- 230000029663 wound healing Effects 0.000 description 5
- 230000003750 conditioning effect Effects 0.000 description 4
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 235000020774 essential nutrients Nutrition 0.000 description 4
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 241000209140 Triticum Species 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000013350 formula milk Nutrition 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 210000003689 pubic bone Anatomy 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 235000000639 cyanocobalamin Nutrition 0.000 description 2
- 239000011666 cyanocobalamin Substances 0.000 description 2
- 229960002104 cyanocobalamin Drugs 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- YOZNUFWCRFCGIH-BYFNXCQMSA-L hydroxocobalamin Chemical compound O[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O YOZNUFWCRFCGIH-BYFNXCQMSA-L 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- 235000020238 sunflower seed Nutrition 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- IELOKBJPULMYRW-IKTKBOKFSA-N 4-oxo-4-[[(2S)-2,5,7,8-tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl]oxy]butanoic acid Chemical compound CC(C)CCC[C@H](C)CCC[C@H](C)CCC[C@@](C)(CC1)Oc(c(C)c2C)c1c(C)c2OC(CCC(O)=O)=O IELOKBJPULMYRW-IKTKBOKFSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 235000019890 Amylum Nutrition 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 239000001736 Calcium glycerylphosphate Substances 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- 239000004260 Potassium ascorbate Substances 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229940100609 all-trans-retinol Drugs 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229940047036 calcium ascorbate Drugs 0.000 description 1
- 239000011692 calcium ascorbate Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229960002713 calcium chloride Drugs 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 description 1
- 229940095618 calcium glycerophosphate Drugs 0.000 description 1
- 235000019299 calcium glycerylphosphate Nutrition 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 229940087373 calcium oxide Drugs 0.000 description 1
- 235000012255 calcium oxide Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229940095672 calcium sulfate Drugs 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- MKJXYGKVIBWPFZ-CEOVSRFSSA-L calcium;(2s)-2-hydroxypropanoate Chemical compound [Ca+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O MKJXYGKVIBWPFZ-CEOVSRFSSA-L 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 239000011706 ferric diphosphate Substances 0.000 description 1
- 235000007144 ferric diphosphate Nutrition 0.000 description 1
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 description 1
- 229940036404 ferric pyrophosphate Drugs 0.000 description 1
- 239000011773 ferrous fumarate Substances 0.000 description 1
- 235000002332 ferrous fumarate Nutrition 0.000 description 1
- 229960000225 ferrous fumarate Drugs 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 229960001781 ferrous sulfate Drugs 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000004867 hydroxocobalamin Nutrition 0.000 description 1
- 239000011704 hydroxocobalamin Substances 0.000 description 1
- 229960001103 hydroxocobalamin Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- -1 isomaltulose oligosaccharide Chemical class 0.000 description 1
- 229940057917 medium chain triglycerides Drugs 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229940017794 potassium ascorbate Drugs 0.000 description 1
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 1
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 1
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004491 retinal development Effects 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- GQTHJBOWLPZUOI-FJXQXJEOSA-M sodium D-pantothenate Chemical compound [Na+].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O GQTHJBOWLPZUOI-FJXQXJEOSA-M 0.000 description 1
- 235000019188 sodium D-pantothenate Nutrition 0.000 description 1
- 239000011756 sodium D-pantothenate Substances 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
- 229960000314 zinc acetate Drugs 0.000 description 1
- 235000013904 zinc acetate Nutrition 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 229960001939 zinc chloride Drugs 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- 239000011576 zinc lactate Substances 0.000 description 1
- 235000000193 zinc lactate Nutrition 0.000 description 1
- 229940050168 zinc lactate Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/10—Meat meal or powder; Granules, agglomerates or flakes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L15/00—Egg products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Pediatric Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention provides a nutritional composite powder for lying-in women in a lactation period and a preparation method thereof, and relates to the technical field of nutritional composite powder for lying-in women, wherein the nutritional composite powder for lying-in women in the lactation period comprises the following components, by mass, 2.5-4.5 parts of A-type protein, 17.5-30.5 parts of B-type protein, 8-13 parts of fat, 40-60 parts of carbohydrate, 3.5-6 parts of dietary fiber prebiotics, 0.09-0.2 part of mineral substances, 0.13-0.28 part of vitamins, 0.1-0.3 part of docosahexaenoic acid and 3-10 parts of traditional food raw materials in the lactation period, wherein the A-type protein comprises 1.4-2.6 parts of fish collagen peptide, 0.7-1.3 part of cartilage collagen and 0.4-0.6 part of peanut peptide powder. The invention combines a plurality of nutrient substances and the traditional puerperal and puerperal dietary habits to supplement the dual nutrition of the puerperal and the fetus, promotes the milk secretion and has good taste; meanwhile, the water-soluble dietary fiber prebiotics and the fish collagen peptide are added, so that the food is particularly suitable for pregnant women after caesarean section who suffer from constipation due to operation and the requirements on healing of operation wounds.
Description
Technical Field
The invention relates to the technical field of nutritional composite powder for lying-in women, and particularly relates to nutritional composite powder for lying-in women in a lactation period and a preparation method thereof.
Background
After the parturient is born, because of the loss of essence and blood, the damage of primordial qi, the deficiency and cold of physique, the symptoms of continuous lochiorrhea, stasis and abdominal pain, intestinal dryness and the like, the traditional Chinese medicine usually recommends to select and take biochemical decoction, black-bone chicken and white phoenix pills and the like, but the medicines mainly have the effects of activating blood and dissolving stasis, warming channels and relieving pain, or tonifying qi, benefiting blood and regulating menstruation, are usually heavy in treatment and light in nourishing, neglect the conditioning of postpartum weak physique, and therefore, the parturient cannot be recovered quickly and effectively, and the wound healing effect is. Moreover, the medicines are bitter in taste and troublesome to take, and patients are difficult to insist on taking the medicines for a long time; and some puerpera need to promote lactation artificially after production, which is inconvenient.
Disclosure of Invention
The invention solves the problems that the medicine taken by the existing puerpera after production can not quickly and effectively recover the puerpera, and the wound healing effect is not good enough; moreover, the medicines are bitter in taste and troublesome to take, and patients are difficult to insist on taking the medicines for a long time; and some lying-in women need to have the assistance of artificial lactation promotion after production, which is at least one of inconvenient.
In order to solve the problems, the invention provides nutritional compound powder for puerperal in lactation, which comprises the following components, by mass, 2.5-4.5 parts of A-type protein, 17.5-30.5 parts of B-type protein, 8-13 parts of fat, 40-60 parts of carbohydrate, 3.5-6 parts of dietary fiber prebiotics, 0.09-0.2 part of mineral substances, 0.13-0.28 part of vitamin, 0.1-0.3 part of docosahexaenoic acid and 3-10 parts of traditional lactation food raw materials, wherein the A-type protein comprises 1.4-2.6 parts of fish collagen peptide, 0.7-1.3 part of cartilage collagen and 0.4-0.6 part of peanut peptide powder.
Optionally, the type B protein is selected from one or more of soy protein isolate, concentrated whey protein, hydrolyzed whey protein, skim milk powder, whole milk powder, concentrated milk protein, bovine colostrum powder, lactoferrin, wheat oligopeptide, marine fish oligopeptide, corn oligopeptide and soy oligopeptide.
Optionally, the vitamin is selected from one or more of vitamin A, vitamin D, vitamin E, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, nicotinic acid, folic acid, and pantothenic acid.
Optionally, the vitamins include vitamin A0.0005-0.0017 parts, vitamin D0.000001-0.000002 parts, vitamin E0.000008-0.000018 parts, vitamin B10.0009-0.0022 parts, vitamin B20.0009-0.0022 parts, vitamin B60.0007-0.0022 parts, vitamin B120.000003-0.000006 parts, vitamin C0.1-0.22 parts, nicotinic acid 0.015-0.03 parts, folic acid 0.0002-0.0006 parts, and pantothenic acid 0.003-0.008 parts.
Optionally, the fat is selected from one or more of vegetable fat powder, sunflower seed oil powder, linseed oil powder, soybean oil powder, olive oil powder and medium chain triglyceride.
Optionally, the carbohydrate is selected from one or more of maltodextrin, lactose, crystalline fructose, corn syrup solids, and starch sugar.
Optionally, the dietary fiber prebiotics are selected from one or more of fructo-oligosaccharide, xylo-oligosaccharide, stachyose, galacto-oligosaccharide, isomalto-oligosaccharide, inulin, resistant dextrin and polydextrose.
Optionally, the minerals comprise calcium, iron and zinc.
Optionally, the traditional lactation food raw material is selected from one or more of egg yolk powder, whole egg powder, yam powder, lotus seed powder, lotus root starch, peanut powder, jujube powder, millet powder, black sesame powder, corn flour, brown sugar, chicken powder, beef powder, fish powder, vegetable and fruit powder and coarse cereal powder.
Compared with the prior art, the nutrition composite powder for the puerpera in the lactation period has the advantages that:
1. the invention supplements the necessary nutrition needed by the puerpera in the lactation period and the fetus after delivery through protein, fat, carbohydrate, vitamin, mineral and other microelements.
2. The water-soluble dietary fiber prebiotics are used for conditioning constipation symptoms of puerpera caused by operation; the fish collagen and the peanut peptide are beneficial to wound healing and massive bleeding of the puerpera after cesarean section.
3. The cartilage collagen of the invention is a high-quality carrier for supplementing bone calcium, is beneficial to the recovery of heavy injury to pubis caused by the fact that the upper body load is increased due to the rapid growth of a fetus in the gestation period, and mineral substances supplement a large amount of deficient calcium in the gestation period and calcium nutrition for the growth and development of the fetus in a natural organic calcium form.
4. The invention promotes the lactation of the pregnant women in the lactation period and improves the milk quality through the traditional food raw materials and proteins in the lactation period.
5. Compared with traditional Chinese medicines, the nutritional composite powder for the puerpera in the lactation period has sweet taste and good mouthfeel.
In order to solve the technical problems, the invention also provides a preparation method of the nutritional composite powder for the lying-in woman in the lactation period, which comprises the following steps:
step S1, grinding and sieving vitamins and minerals, and premixing with carbohydrate by an equivalent progressive method to prepare premix 1;
step S2, mixing the premix 1 prepared in the step S1 with traditional lactation food raw materials, docosahexaenoic acid and dietary fiber prebiotics for 10-15 minutes to prepare a premix 2;
step S3, mixing the premix 2 prepared in the step S2 and the carbohydrate for 10-20 minutes, adding the protein A, the protein B, the fat and the carbohydrate according to the principle of adding the same amount in a gradual manner, continuously mixing for 30-45 minutes, discharging, and preparing the nutritional compound powder for the puerpera in the lactation period;
the mass ratio of the carbohydrate added in the three steps is (5-9): 34-38): 55-59 in sequence.
The preparation method of the lactation puerperal nutrition compound powder has the same advantages of the lactation puerperal nutrition compound powder compared with the prior art, and the preparation method is not repeated.
Drawings
Fig. 1 is a flow chart of a preparation method of the nutritional compound powder for the puerpera in the lactation period in the embodiment of the invention.
Detailed Description
In order to make the aforementioned objects, features and advantages of the present invention comprehensible, embodiments accompanied with figures are described in detail below.
The description of the term "some specific embodiments" means that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one embodiment or example of the invention. Throughout this specification, the schematic representations of the terms used above do not necessarily refer to the same implementation or example. Furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples.
It should be noted that the terms "class a" and "class B" in the present embodiment are used for descriptive purposes only and are not to be construed as indicating or implying relative importance or implicitly indicating the category of the indicated technical feature. Thus, a feature defined as "class a" or "class B" may explicitly or implicitly include at least one technical feature of that class.
The embodiment of the invention provides a lactation period lying-in woman nutrition composite powder which comprises, by mass, 2.5-4.5 parts of A-type protein, 17.5-30.5 parts of B-type protein, 8-13 parts of fat, 40-60 parts of carbohydrate, 3.5-6 parts of dietary fiber prebiotics, 0.09-0.2 part of mineral substances, 0.13-0.28 part of vitamin, 0.1-0.3 part of docosahexaenoic acid and 3-10 parts of traditional lactation period food raw materials, wherein the A-type protein comprises 1.4-2.6 parts of fish collagen peptide, 0.7-1.3 parts of cartilage collagen and 0.4-0.6 part of peanut peptide powder. Wherein, the cartilage collagen is a high-quality carrier for supplementing bone calcium, which is beneficial to the recovery of heavy injury to the pubis caused by the increase of the upper body load due to the rapid growth of a fetus in the gestation period; the fish collagen and the peanut peptide are beneficial to wound healing and massive bleeding of the puerpera after cesarean section.
In some preferred embodiments, the class B protein is selected from one or more of soy protein isolate, concentrated whey protein, hydrolyzed whey protein, skim milk powder, whole milk powder, concentrated milk protein, bovine colostrum powder, lactoferrin, wheat oligopeptide, marine fish oligopeptide, corn oligopeptide, and soy oligopeptide. Effectively supplements protein essential nutrient substances needed by the puerpera in the lactation period and the fetus after delivery.
In some preferred embodiments, the vitamin is selected from one or more of vitamin a, vitamin D, vitamin E, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, niacin, folic acid, and pantothenic acid.
Optionally, the vitamins include vitamin A0.0005-0.0017 parts, vitamin D0.000001-0.000002 parts, vitamin E0.000008-0.000018 parts, vitamin B10.0009-0.0022 parts, vitamin B20.0009-0.0022 parts, vitamin B60.0007-0.0022 parts, vitamin B120.000003-0.000006 parts, vitamin C0.1-0.22 parts, nicotinic acid 0.015-0.03 parts, folic acid 0.0002-0.0006 parts, and pantothenic acid 0.003-0.008 parts.
In some specific embodiments of the present invention,
vitamin A is selected from one or more of retinyl acetate, retinyl palmitate, β -carotene, and all-trans retinol;
vitamin D is selected from ergocalciferol and cholecalciferol, and vitamin E is selected from one or more of dl- α -tocopherol, dl- α -tocopherol acetate, mixed tocopherol concentrate, and dl- α -tocopherol succinate;
vitamin B1 is selected from one or more of thiamine hydrochloride and thiamine nitrate;
vitamin B2 is selected from riboflavin, riboflavin-5' -sodium phosphate; vitamin B6 is selected from pyridoxine hydrochloride, pyridoxal 5' -phosphate;
vitamin B12 is selected from one or more of cyanocobalamin, cyanocobalamin hydrochloride and hydroxocobalamin;
vitamin C is selected from L-ascorbic acid, L-sodium ascorbate, L-calcium ascorbate, L-potassium ascorbate, and ascorbic acid-6-palmitate;
the nicotinic acid is one or more of nicotinic acid and nicotinamide;
the folic acid is selected from folic acid (pteroylglutamic acid); one or more of calcium D-pantothenate, sodium D-pantothenate;
or all vitamins are selected from compound nutrition enhancers, so that essential nutrient substances of the vitamins required by the puerpera in the lactation period and the fetus after delivery are effectively supplemented.
In some preferred embodiments, the fat is selected from one or more of vegetable fat powder, sunflower oil powder, linseed oil powder, soybean oil powder, olive oil powder, medium chain triglycerides. Effectively supplements the fat essential nutrient substances needed by the puerpera in the lactation period and the fetus after delivery.
In some preferred embodiments, the carbohydrate is selected from one or more of maltodextrin, lactose, crystalline fructose, corn syrup solids, and starch sugar. Effectively supplements carbohydrate essential nutrient substances needed by the parturient in the lactation period and the fetus after delivery.
In some preferred embodiments, the dietary fiber prebiotic is selected from one or more of fructo-oligosaccharide, xylo-oligosaccharide, stachyose, galacto-oligosaccharide, isomaltulose-oligosaccharide, inulin, resistant dextrin, polydextrose. In the embodiment, the dietary fiber prebiotics are water-soluble dietary fiber prebiotics and are used for conditioning constipation symptoms of puerpera caused by operations.
In some preferred embodiments, the minerals include calcium, iron, and zinc. Wherein,
the calcium is selected from one or more of calcium carbonate, calcium gluconate, L-calcium lactate, calcium hydrogen phosphate, calcium glycerophosphate, calcium chloride, tricalcium phosphate, calcium oxide, and calcium sulfate;
the iron is selected from one or more of ferrous sulfate, ferrous gluconate, ferrous fumarate and ferric pyrophosphate;
the zinc is selected from one or more of zinc sulfate, zinc gluconate, zinc oxide, zinc lactate, zinc citrate, zinc chloride, and zinc acetate.
In this example, the minerals are in the form of natural organic calcium to supplement the calcium that is largely absent during pregnancy and the calcium nutrition for the growth and development of the fetus.
In some preferred embodiments, the docosahexaenoic acid (DHA) is selected from fish oil microcapsule powder or DHA algal oil powder. In the embodiment, the medicine is indirectly supplemented to the infants through the mothers, so that the delay or obstruction of the retinal development process, mental retardation and visual disturbance of the infants are avoided.
In some preferred embodiments, the traditional lactation food raw material is selected from one or more of egg yolk powder, whole egg powder, yam powder, lotus seed powder, lotus root starch, peanut powder, jujube powder, millet powder, black sesame powder, corn powder, brown sugar, chicken powder, beef powder, fish powder, vegetable and fruit powder and coarse cereal powder. The embodiment promotes the lactation of the pregnant women in the lactation period and improves the milk quality through the traditional food raw materials and proteins in the lactation period.
In the embodiment, because the nutrition demand of the newborn baby is relatively high and is mainly provided by breast milk of a mother, the embodiment combines various nutrient substances and the traditional puerperal and confinement eating habits to supplement dual nutrition of the puerpera and the fetus, and simultaneously adds the water-soluble dietary fiber prebiotics and the fish collagen peptide, so that the infant formula is particularly suitable for the pregnant women after caesarean section who are accompanied by constipation due to operation and the requirements of healing of operation wounds, and is particularly shown in the following steps:
1. the invention supplements the necessary nutrition needed by the puerpera in the lactation period and the fetus after delivery through protein, fat, carbohydrate, vitamin, mineral and other microelements.
2. The water-soluble dietary fiber prebiotics are used for conditioning constipation symptoms of puerpera caused by operation; the fish collagen and the peanut peptide are beneficial to wound healing and massive bleeding of the puerpera after cesarean section.
3. The cartilage collagen of the invention is a high-quality carrier for supplementing bone calcium, is beneficial to the recovery of heavy injury to pubis caused by the fact that the upper body load is increased due to the rapid growth of a fetus in the gestation period, and mineral substances supplement a large amount of deficient calcium in the gestation period and calcium nutrition for the growth and development of the fetus in a natural organic calcium form.
4. The invention promotes the lactation of the pregnant women in the lactation period and improves the milk quality through the traditional food raw materials and proteins in the lactation period.
5. Compared with traditional Chinese medicines, the nutritional composite powder for the puerpera in the lactation period has sweet taste and good mouthfeel.
In order to solve the technical problems, the embodiment of the invention also provides a preparation method of the nutritional compound powder for the puerpera in the lactation period. As shown in fig. 1, the method comprises the following steps:
step S1, grinding and sieving vitamins and minerals, and premixing with carbohydrate by an equivalent progressive method to prepare premix 1;
step S2, mixing the premix 1 prepared in the step S1 with traditional lactation food raw materials, docosahexaenoic acid and dietary fiber prebiotics for 10-15 minutes to prepare a premix 2;
step S3, mixing the premix 2 prepared in the step S2 and the carbohydrate for 10-20 minutes, adding the protein A, the protein B, the fat and the carbohydrate according to the principle of adding the same amount in a gradual manner, continuously mixing for 30-45 minutes, discharging, and preparing the nutritional compound powder for the puerpera in the lactation period;
the mass ratio of the carbohydrate added in the three steps is (5-9): 34-38): 55-59 in sequence.
In some embodiments, a method for preparing a nutritional composite powder for a lactating parturient comprises the following steps:
step S1, grinding and sieving 0.13-0.28 part of vitamin and 0.09-0.2 part of mineral substance, and premixing with carbohydrate by an equivalent progressive method to prepare premix 1;
step S2, mixing the premix 1 prepared in the step S1 with 3-10 parts of traditional lactation food raw materials, 0.1-0.3 part of docosahexaenoic acid and 3.5-6 parts of dietary fiber prebiotics for 10-15 minutes to prepare a premix 2;
step S3, mixing the premix 2 and the carbohydrate prepared in the step S2 for 10-20 minutes, adding 2.5-4.5 parts of protein A, 17.5-30.5 parts of protein B, 8-13 parts of fat and carbohydrate into the premix according to the principle of equal progressive addition, continuously mixing the mixture for 30-45 minutes, and discharging the mixture to prepare the nutritional compound powder for the puerpera in the lactation period;
the mass of each raw material in the steps is represented by mass parts, wherein the total mass part of the added carbohydrate is 40-60 parts. The mass ratio of the carbohydrate added for three times is (5-9) to (34-38) to (55-59), the carbohydrate is added for three times, all components can be fully mixed into the carbohydrate, the taste is good, and the preparation method of the nutritional compound powder for the puerpera in the lactation period is simple and easy to implement.
Example 1
The nutritional composite powder for the puerpera in the lactation period comprises, by mass, 1.4 parts of fish collagen peptide, 0.7 part of chondroprotein, 0.4 part of peanut peptide powder, 17.5 parts of soybean protein isolate, 8 parts of linseed oil powder, 40 parts of maltodextrin, 3.5 parts of inulin, 0.09 part of mineral substances, 0.0005 part of vitamin A, 0.000001 part of vitamin D, 0.000008 part of vitamin E, 10.0009 parts of vitamin B, 20.0009 parts of vitamin B60.0007 parts, 120.000003 parts of vitamin B, 0.1 part of vitamin C, 0.01 part of nicotinic acid, 0.0002 part of folic acid, 0.003 part of pantothenic acid, 0.1 part of docosahexaenoic acid and 3 parts of yolk powder.
In this embodiment, the isolated soy protein may be replaced by one or more of concentrated whey protein, hydrolyzed whey protein, skim milk powder, whole milk powder, concentrated milk protein, bovine colostrum powder, lactoferrin, wheat oligopeptide, marine fish oligopeptide, corn oligopeptide, and soy oligopeptide.
In this embodiment, the linseed oil powder may be replaced by one or more of vegetable fat powder, sunflower seed oil powder, soybean oil powder, olive oil powder, and medium chain triglyceride.
The maltodextrin can be replaced by one or more of lactose, crystalline fructose, corn syrup solids, and starch sugar.
Inulin can be replaced by one or more of fructo-oligosaccharide, xylo-oligosaccharide, stachyose, galacto-oligosaccharide, isomaltulose oligosaccharide, resistant dextrin, and polydextrose.
The yolk powder can be replaced by one or more of whole egg powder, rhizoma Dioscoreae powder, semen Nelumbinis powder, Amylum Nelumbinis Rhizomatis, semen Arachidis Hypogaeae powder, fructus Jujubae powder, semen Setariae powder, semen Sesami Niger powder, semen Maydis powder, brown sugar, Carnis gallus Domesticus powder, Carnis bovis Seu Bubali powder, fish powder, vegetable and fruit powder, and miscellaneous grain powder.
The preparation method of the nutritional composite powder for the puerpera in the lactation period in the embodiment is as follows:
weighing 1.4 parts of fish collagen peptide, 0.7 part of cartilage collagen, 0.4 part of peanut peptide powder, 17.5 parts of soybean protein isolate, 8 parts of linseed oil powder, 40 parts of maltodextrin, 3.5 parts of inulin, 0.09 part of mineral matter, 0.0005 part of vitamin A, 0.000001 part of vitamin D, 0.000008 part of vitamin E, 10.0009 parts of vitamin B, 20.0009 parts of vitamin B60.0007 parts of vitamin B120.000003 parts of vitamin C, 0.1 part of nicotinic acid, 0.0002 part of folic acid, 0.003 part of pantothenic acid, 0.1 part of docosahexaenoic acid and 3 parts of yolk powder according to the following steps:
step S1, grinding and sieving vitamins and minerals, and premixing with maltodextrin in an equivalent progressive method to prepare premix 1;
step S2, mixing the premix 1 prepared in the step S1 with egg yolk powder, docosahexaenoic acid and inulin for 10 minutes to prepare a premix 2;
step S3, mixing the premix 2 prepared in the step S2 and maltodextrin for 10 minutes, adding the fish collagen peptide, the cartilage collagen, the peanut peptide powder, the soybean protein isolate, the linseed oil powder and the maltodextrin according to the principle of equal progressive addition, continuously mixing for 30 minutes, and discharging to prepare the nutritional composite powder for the puerpera in the lactation period;
the mass ratio of the carbohydrates added for three times in the steps is 5:38:57 in sequence.
Example 2
The difference between the embodiment and the embodiment 1 is that the nutritional compound powder for the puerperal women in the lactation period comprises the following components, by mass, 2 parts of fish collagen peptide, 1 part of chondrocollagen and 0.5 part of peanut peptide powder, 25 parts of soybean protein isolate, 10 parts of linseed oil powder, 50 parts of maltodextrin, 5 parts of inulin, 0.15 part of mineral substances, 0.001 part of vitamin A, 0.000001 part of vitamin D, 0.00001 part of vitamin E, 0. 10.0013 part of vitamin B, 20.0013 parts of vitamin B60.0015 parts, 0. 120.000004 part of vitamin B, 0.16 part of vitamin C, 0.02 part of nicotinic acid, 0.0004 part of folic acid, 0.005 part of pantothenic acid, 0.2 part of docosahexaenoic acid and 5 parts of egg yolk powder.
The preparation method of the nutritional composite powder for the puerpera in the lactation period in the embodiment is as follows:
weighing 2 parts of fish collagen peptide, 1 part of cartilage collagen, 0.5 part of peanut peptide powder, 25 parts of soybean protein isolate, 10 parts of linseed oil powder, 50 parts of maltodextrin, 5 parts of inulin, 0.15 part of mineral substances, 0.001 part of vitamin A, 0.000001 part of vitamin D, 0.00001 part of vitamin E, 10.0013 parts of vitamin B, 20.0013 parts of vitamin B, 60.0015 parts of vitamin B, 120.000004 parts of vitamin C, 0.16 part of nicotinic acid, 0.0004 part of folic acid, 0.005 part of pantothenic acid, 0.2 part of docosahexaenoic acid and 5 parts of yolk powder according to the formula.
The method is orderly carried out according to the following steps:
step S1, grinding and sieving vitamins and minerals, and premixing with maltodextrin in an equivalent progressive method to prepare premix 1;
step S2, mixing the premix 1 prepared in the step S1 with egg yolk powder, docosahexaenoic acid and inulin for 12 minutes to prepare a premix 2;
step S3, mixing the premix 2 prepared in the step S2 and maltodextrin for 15 minutes, adding the fish collagen peptide, the cartilage collagen, the peanut peptide powder, the soybean protein isolate, the linseed oil powder and the maltodextrin according to the principle of equal progressive addition, continuously mixing for 38 minutes, and discharging to prepare the nutritional composite powder for the puerpera in the lactation period;
the mass ratio of the carbohydrates added for three times in the steps is 7:35:58 in sequence.
Example 3
The difference between the embodiment and the embodiment 1 is that the nutritional composite powder for the puerperal women in the lactation period comprises the following components, by mass, 2.6 parts of fish collagen peptide, 1.3 parts of chondrocollagen and 0.6 part of peanut peptide powder, 30.5 parts of soybean protein isolate, 13 parts of linseed oil powder, 60 parts of maltodextrin, 6 parts of inulin, 0.2 part of mineral matter, 0.0017 part of vitamin A, 0.000002 part of vitamin D, 0.000018 part of vitamin E, 10.0022 parts of vitamin B, 20.0022 parts of vitamin B60.0022, 120.000006 parts of vitamin B, 0.22 part of vitamin C, 0.03 part of nicotinic acid, 0.0006 part of folic acid, 0.008 part of pantothenic acid, 0.3 part of docosahexaenoic acid and 10 parts of yolk powder.
The preparation method of the nutritional composite powder for the puerpera in the lactation period in the embodiment is as follows:
weighing 2.6 parts of fish collagen peptide, 1.3 parts of cartilage collagen, 0.6 part of peanut peptide powder, 30.5 parts of soybean protein isolate, 13 parts of linseed oil powder, 60 parts of maltodextrin, 6 parts of inulin, 0.2 part of mineral substances, 0.0017 part of vitamin A, 0.000002 part of vitamin D, 0.000018 parts of vitamin E, 10.0022 parts of vitamin B, 20.0022 parts of vitamin B, 60.0022 parts of vitamin B12 and the like according to the formula
0.000006 part, 0.22 part of vitamin C, 0.03 part of nicotinic acid, 0.0006 part of folic acid, 0.008 part of pantothenic acid, 0.3 part of docosahexaenoic acid and 10 parts of egg yolk powder.
The method is orderly carried out according to the following steps:
step S1, grinding and sieving vitamins and minerals, and premixing with maltodextrin in an equivalent progressive method to prepare premix 1;
step S2, mixing the premix 1 prepared in the step S1 with egg yolk powder, docosahexaenoic acid and inulin for 15 minutes to prepare a premix 2;
step S3, mixing the premix 2 prepared in the step S2 and maltodextrin for 20 minutes, adding the fish collagen peptide, the cartilage collagen, the peanut peptide powder, the soybean protein isolate, the linseed oil powder and the maltodextrin according to the principle of equivalent progressive addition, continuously mixing for 45 minutes, and discharging to prepare the nutritional composite powder for the puerpera in the lactation period;
the mass ratio of the carbohydrates added for three times in the steps is 7:35:58 in sequence.
Although the present invention is disclosed above, the present invention is not limited thereto. Various changes and modifications may be effected therein by one skilled in the art without departing from the spirit and scope of the invention as defined in the appended claims.
Claims (10)
1. The nutritional composite powder for the lying-in women in the lactation period is characterized by comprising the following components in parts by mass: 2.5-4.5 parts of A-type protein, 17.5-30.5 parts of B-type protein, 8-13 parts of fat, 40-60 parts of carbohydrate, 3.5-6 parts of dietary fiber prebiotics, 0.09-0.2 part of mineral substances, 0.13-0.28 part of vitamin, 0.1-0.3 part of docosahexaenoic acid and 3-10 parts of traditional lactation food raw materials, wherein the A-type protein comprises 1.4-2.6 parts of fish collagen peptide, 0.7-1.3 parts of cartilage collagen and 0.4-0.6 part of peanut peptide powder.
2. The composite nutritional powder according to claim 1, wherein the B-type protein is selected from one or more of soy protein isolate, concentrated whey protein, hydrolyzed whey protein, skim milk powder, whole milk powder, concentrated milk protein, bovine colostrum powder, lactoferrin, wheat oligopeptide, marine fish oligopeptide, corn oligopeptide and soy oligopeptide.
3. The nutrition composite powder for lying-in women according to claim 1, wherein the vitamins are selected from one or more of vitamin A, vitamin D, vitamin E, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, niacin, folic acid, and pantothenic acid.
4. The nutritional composite powder of claim 3, wherein the vitamins comprise 0.0005 to 0.0017 parts of vitamin A, 0.000001 to 0.000002 parts of vitamin D, 0.000008 to 0.000018 parts of vitamin E, 10.0009 to 0.0022 parts of vitamin B, 20.0009 to 0.0022 parts of vitamin B, 60.0007 to 0.0022 parts of vitamin B, 120.000003 to 0.000006 parts of vitamin B, 0.1 to 0.22 parts of vitamin C, 0.015 to 0.03 parts of niacin, 0.0002 to 0.0006 parts of folic acid, and 0.003 to 0.008 parts of pantothenic acid.
5. The compound powder as claimed in claim 1, wherein the fat is selected from one or more of vegetable fat powder, sunflower oil powder, linseed oil powder, soybean oil powder, olive oil powder, and medium chain triglyceride.
6. The nutritional composite powder for puerpera during lactation period according to claim 1, wherein the carbohydrate is selected from one or more of maltodextrin, lactose, crystalline fructose, corn solid syrup and starch sugar.
7. The nutritional composite powder for puerperal lactation according to claim 1, wherein the dietary fiber prebiotics are selected from one or more of fructo-oligosaccharide, xylo-oligosaccharide, stachyose, galacto-oligosaccharide, isomaltulose-oligosaccharide, inulin, resistant dextrin and polydextrose.
8. The composite nutritional powder for lactating women according to claim 1, wherein the minerals comprise calcium, iron and zinc.
9. The composite nutritional powder for lying-in women according to claim 1, wherein the traditional food materials for lying-in women are selected from one or more of egg yolk powder, whole egg powder, yam powder, lotus seed powder, lotus root starch, peanut powder, jujube powder, millet powder, black sesame powder, corn flour, brown sugar, chicken powder, beef powder, fish powder, vegetable and fruit powder and coarse cereal powder.
10. A method for preparing a nutritional composite powder for lactating women, which is used for preparing the nutritional composite powder for lactating women as claimed in any one of claims 1 to 9, and which comprises the following steps:
step S1, grinding and sieving vitamins and minerals, and premixing with carbohydrate by an equivalent progressive method to prepare premix 1;
step S2, mixing the premix 1 prepared in the step S1 with traditional lactation food raw materials, docosahexaenoic acid and dietary fiber prebiotics for 10-15 minutes to prepare a premix 2;
step S3, mixing the premix 2 prepared in the step S2 and the carbohydrate for 10-20 minutes, adding the protein A, the protein B, the fat and the carbohydrate according to the principle of adding the proteins in equal amount in a gradual manner, continuously mixing for 30-45 minutes, and discharging to obtain the nutritional compound powder for the puerpera in the lactation period;
the mass ratio of the carbohydrate added in the three steps is (5-9): 34-38): 55-59 in sequence.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010452809.3A CN111480838A (en) | 2020-05-26 | 2020-05-26 | Nutrition composite powder for puerpera in lactation period and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010452809.3A CN111480838A (en) | 2020-05-26 | 2020-05-26 | Nutrition composite powder for puerpera in lactation period and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111480838A true CN111480838A (en) | 2020-08-04 |
Family
ID=71795731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010452809.3A Pending CN111480838A (en) | 2020-05-26 | 2020-05-26 | Nutrition composite powder for puerpera in lactation period and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111480838A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113383821A (en) * | 2021-05-20 | 2021-09-14 | 浙江核力欣健药业有限公司 | Special nutrition formula powder for puerperal women and preparation method thereof |
| CN114343054A (en) * | 2022-01-12 | 2022-04-15 | 安徽爱不停蛋白质饲料有限公司 | Compound premix capable of improving lactation capacity of animals |
| CN116439368A (en) * | 2023-06-16 | 2023-07-18 | 四川大学华西第二医院 | Nutritional composition for pregnant women and preparation method thereof |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999053777A1 (en) * | 1998-04-22 | 1999-10-28 | Novartis Nutrition Ag | Nutritional supplement for pregnant and lactating women |
| CN106798074A (en) * | 2015-11-26 | 2017-06-06 | 青岛智信生物科技有限公司 | A kind of deep-sea fish oligopeptide albumen powder with enhance immunity function |
| CN106804872A (en) * | 2015-12-01 | 2017-06-09 | 青岛智信生物科技有限公司 | A kind of deep-sea fish oligopeptide albumen powder with human body anti-oxidation function |
| CN107927754A (en) * | 2017-12-13 | 2018-04-20 | 上海奥医生物医药科技有限公司 | Tailored version clinical nutrition formula and preparation method thereof is energized during one kind production |
| CN108576234A (en) * | 2018-04-10 | 2018-09-28 | 中食月太(北京)健康科技有限公司 | Improve the food and preparation method thereof of cesarean lactation amount |
| CN108634324A (en) * | 2018-04-10 | 2018-10-12 | 陕西三正医用营养有限公司 | A kind of special diet food and preparation method thereof promoting cesarean lactation and nutritional supplementation |
| CN108719720A (en) * | 2018-06-06 | 2018-11-02 | 唐山肽景堂生物科技有限公司 | A kind of solid beverage and preparation method thereof of benefit breast milk abundance peptide compounding |
| CN110179125A (en) * | 2019-05-29 | 2019-08-30 | 山东腾贵医药有限公司 | A kind of composition and preparation method thereof promoting Recovery |
| CN110771879A (en) * | 2019-11-07 | 2020-02-11 | 上海奥医生物医药科技有限公司 | Lactation promoting clinical nutrition formula and preparation method thereof |
| CN110839884A (en) * | 2019-12-04 | 2020-02-28 | 上海张新生物医药科技有限公司 | Nutritional composition for improving body inflammatory signs of tumor patients and preparation method thereof |
-
2020
- 2020-05-26 CN CN202010452809.3A patent/CN111480838A/en active Pending
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999053777A1 (en) * | 1998-04-22 | 1999-10-28 | Novartis Nutrition Ag | Nutritional supplement for pregnant and lactating women |
| CN106798074A (en) * | 2015-11-26 | 2017-06-06 | 青岛智信生物科技有限公司 | A kind of deep-sea fish oligopeptide albumen powder with enhance immunity function |
| CN106804872A (en) * | 2015-12-01 | 2017-06-09 | 青岛智信生物科技有限公司 | A kind of deep-sea fish oligopeptide albumen powder with human body anti-oxidation function |
| CN107927754A (en) * | 2017-12-13 | 2018-04-20 | 上海奥医生物医药科技有限公司 | Tailored version clinical nutrition formula and preparation method thereof is energized during one kind production |
| CN108576234A (en) * | 2018-04-10 | 2018-09-28 | 中食月太(北京)健康科技有限公司 | Improve the food and preparation method thereof of cesarean lactation amount |
| CN108634324A (en) * | 2018-04-10 | 2018-10-12 | 陕西三正医用营养有限公司 | A kind of special diet food and preparation method thereof promoting cesarean lactation and nutritional supplementation |
| CN108719720A (en) * | 2018-06-06 | 2018-11-02 | 唐山肽景堂生物科技有限公司 | A kind of solid beverage and preparation method thereof of benefit breast milk abundance peptide compounding |
| CN110179125A (en) * | 2019-05-29 | 2019-08-30 | 山东腾贵医药有限公司 | A kind of composition and preparation method thereof promoting Recovery |
| CN110771879A (en) * | 2019-11-07 | 2020-02-11 | 上海奥医生物医药科技有限公司 | Lactation promoting clinical nutrition formula and preparation method thereof |
| CN110839884A (en) * | 2019-12-04 | 2020-02-28 | 上海张新生物医药科技有限公司 | Nutritional composition for improving body inflammatory signs of tumor patients and preparation method thereof |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113383821A (en) * | 2021-05-20 | 2021-09-14 | 浙江核力欣健药业有限公司 | Special nutrition formula powder for puerperal women and preparation method thereof |
| CN114343054A (en) * | 2022-01-12 | 2022-04-15 | 安徽爱不停蛋白质饲料有限公司 | Compound premix capable of improving lactation capacity of animals |
| CN116439368A (en) * | 2023-06-16 | 2023-07-18 | 四川大学华西第二医院 | Nutritional composition for pregnant women and preparation method thereof |
| CN116439368B (en) * | 2023-06-16 | 2023-09-15 | 四川大学华西第二医院 | Nutritional composition for pregnant women and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106490605A (en) | A kind of hypertension of pregnancy tailored version clinical nutrition formula and preparation method thereof | |
| CN103392759B (en) | Composite flour for pregnant women | |
| CN101530195B (en) | A special dietary food formula containing short peptides for puerpera | |
| CN111480838A (en) | Nutrition composite powder for puerpera in lactation period and preparation method thereof | |
| CN109287759A (en) | A kind of formula milk and production method helping child height development | |
| CN106666728A (en) | Special clinical nutrient composition for gestational diabetes and preparation method of nutrient composition | |
| CN106579393A (en) | Special clinical nutrient formula for diabetes and preparation method thereof | |
| CN106983136A (en) | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof | |
| CN107927754A (en) | Tailored version clinical nutrition formula and preparation method thereof is energized during one kind production | |
| CN108651988A (en) | Nephrosis dialysis tailored version clinical nutrition formula and preparation method thereof | |
| CN103002757A (en) | premature milk formula | |
| CN106135425A (en) | The milk protein powder that a kind of applicable pregnant food in one's mouth phase is edible | |
| CN108634324A (en) | A kind of special diet food and preparation method thereof promoting cesarean lactation and nutritional supplementation | |
| CN110214941A (en) | A kind of full nutrition special medicine purposes formula nutritional powder of adult and preparation method thereof | |
| CN108013453A (en) | Children's lactose intolerance tailored version clinical nutrition formula and preparation method thereof | |
| CN110074397A (en) | A kind of upgrowth and development of children tailored version clinical nutrition formula and preparation method thereof | |
| CN110771879A (en) | Lactation promoting clinical nutrition formula and preparation method thereof | |
| CN108013452A (en) | A kind of puerperal abdominal flatulence gas tailored version clinical nutrition formula and preparation method thereof | |
| CN110771869A (en) | Third-stage full-nutrition breakfast for pregnant women and preparation method thereof | |
| RU2080072C1 (en) | Dairy product for pregnant women and nursing mothers | |
| CN111602719A (en) | Organic formula milk powder for pregnant and lying-in women | |
| Talebi et al. | Nutritional requirements in pregnancy and lactation | |
| CN105639461A (en) | Supplementary food nutritional supplement and preparation method thereof | |
| CN114271335A (en) | Dairy product and method for producing the same | |
| CN106173572A (en) | A kind of maternal nutritional fortified compositions and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200804 |